| dc.contributor.author | Dulgar, Ozgecan | |
| dc.contributor.author | TURNA, Zeynep Hande | |
| dc.contributor.author | İLVAN, Şennur | |
| dc.date.accessioned | 2021-03-02T16:47:14Z | |
| dc.date.available | 2021-03-02T16:47:14Z | |
| dc.date.issued | 2020 | |
| dc.identifier.citation | Dulgar O., İLVAN Ş., TURNA Z. H. , "Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer", EUROPEAN JOURNAL OF BREAST HEALTH, cilt.16, sa.4, ss.276-281, 2020 | |
| dc.identifier.other | vv_1032021 | |
| dc.identifier.other | av_49177e59-c57c-4dea-910d-d627d62a8d08 | |
| dc.identifier.uri | http://hdl.handle.net/20.500.12627/3291 | |
| dc.identifier.uri | https://doi.org/10.5152/ejbh.2020.5305 | |
| dc.description.abstract | Objective: Triple-negative-breast-cancer (TNBC) is a very heterogenous disease some of which are very aggressive and have poor prognosis. No targeted therapy is available. Immune response and tumor-infiltrating lymphocytes (TIL) can be related to longer disease-free survival (DFS) and overall survival (OS) in TNBC. Family history of cancer can be related poor prognosis, irrespective of genetic mutation. | |
| dc.language.iso | eng | |
| dc.subject | İç Hastalıkları | |
| dc.subject | Onkoloji | |
| dc.subject | Sağlık Bilimleri | |
| dc.subject | Dahili Tıp Bilimleri | |
| dc.subject | Tıp | |
| dc.subject | Klinik Tıp (MED) | |
| dc.subject | Klinik Tıp | |
| dc.subject | ONKOLOJİ | |
| dc.title | Prognostic Factors and Tumor Infiltrating Lymphocytes in Triple Negative Breast Cancer | |
| dc.type | Makale | |
| dc.relation.journal | EUROPEAN JOURNAL OF BREAST HEALTH | |
| dc.contributor.department | Istanbul Goztepe Training and Research Hospital , , | |
| dc.identifier.volume | 16 | |
| dc.identifier.issue | 4 | |
| dc.identifier.startpage | 276 | |
| dc.identifier.endpage | 281 | |
| dc.contributor.firstauthorID | 2287476 | |
